期刊
EXPERT REVIEW OF CLINICAL PHARMACOLOGY
卷 13, 期 1, 页码 35-42出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/17512433.2020.1698290
关键词
Drug induced lupus; cutaneous lupus erythematosus; subacute cutaneous lupus; chronic cutaneous lupus; cutaneous lupus diagnosis; cutaneous lupus treatment
资金
- Department of Veterans Affairs Veterans Health Administration
- Office of Research and Development
- Biomedical Laboratory Research and Development
- National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases) [R01AR071653]
Introduction: There is a growing list of drugs implicated in inducing both subacute and chronic forms of cutaneous lupus erythematosus. It is important to recognize these drugs in order to quickly treat patients with drug induced disease. Areas covered: This paper reviews the current literature describing drugs implicated in causing cutaneous lupus erythematosus. A Pubmed search was used to compile a list of medications implicated up to August 2019. It reviews new classes of drugs identified as causing cutaneous lupus erythematosus, the pathophysiology of the disease process, and current recommendations for treatment of the disease. Expert opinion: Many drugs have been identified as inducing lupus, and many more continue to be described in new reports. Further research is needed to understand this phenomenon, which will aid in the diagnosis and treatment of affected patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据